(HealthDay)—For patients with hereditary angioedema (HAE), weekly administration of recombinant C1INH (rhC1INH) is well tolerated and is associated with a reduction in attack frequency, according to a study published online ...
Nov 9, 2012
0
0
The Molecular and Industrial Biotechnology Group of the Universitat Politècnica de Catalunya · BarcelonaTech (UPC) has improved the antimicrobial properties of medical textiles using an enzymatic pre-treatment combined ...
Oct 16, 2012
0
0
Biotechnology industry officials are warning that a US Supreme Court ruling on patent rights this week could have a chilling effect on the development of personalized medicine.
Mar 21, 2012
1
0
